Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults
Clinical trial NCT06125691 · COMPLETED
Trial details
- NCT number
- NCT06125691
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2024-08-10
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.